Slide 1Cosa altro è importante sapere oltre lHER2 status: recettori ormonali, profili di espressione genica… LHER2-positività: dallanatamopatologia alla clinica Stefania…
Gabriele Minuti Medical Oncology Division Civil Hospital of Livorno MET as a biomarker for target therapies MET as a biomarker for target therapies MET and its ligand HGF…
RESEARCH ARTICLE Open Access Dual PI3K/mTOR inhibitor BEZ235 exerts extensive antitumor activity in HER2- positive gastric cancer Yan Zhu1†, Tiantian Tian1†, Jianling…
Activation of an IL6 Inflammatory Loop Mediates Trastuzumab Resistance in HER2+ Breast Cancer by Expanding the Cancer Stem Cell Population Hasan Korkaya, Gwang-il Kim,…